Sengenics | Autoantibody Biomarker | Proteomic Technology

Antibody Profiling: Decoding the Humoral Immune System

Get your FREE white paper today!

Discover why antibody biomarkers hold the potential to transform patient care in our comprehensive white paper.

Get White Paper

In this white paper, explore how we can redefine precision medicine:

Early Diagnosis: Understand the power of antibody biomarkers in identifying chronic diseases at their onset.
Treatment Tailoring: Learn how these biomarkers can predict individual treatment responses and mitigate the risk of adverse effects.
Technological Edge: Delve into the precision of Sengenics’ patented KREX® technology for accurate antibody screening.
Impacts on Research: See how antibody biomarkers are not just predictive tools but also key to unlocking disease pathways, essential for novel drug development.

Why Sengenics?

Since 90% of our antibodies target conformational epitopes, accurate autoantibody screening demands correctly-folded proteins – guaranteed by Sengenics KREX technology.

Discover why Sengenics excels in immunoproteomics:

Full-length, correctly folded proteins
Picomolar sensitivity
Highly reproducible
Low sample consumption
Wide dynamic range
High throughput
Simultaneous analysis of two antibody isotype (e.g., IgA and IgA or IgM)
Off-the-shelf and custom options
Distributors and service providers worldwide

With one of Sengenics high-density arrays, i-Ome® Discovery, screen against more than 1800 autoimmune, cancer, and neurological disease-related antigens in a single assay. Learn more

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Antibody Profiling: Decoding the Humoral Immune System

Why Sengenics?

Fill in the form to download the publication

Watch the video

Watch the video

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Watch the video